A stunning mental health breakthrough has unleashed a massive opportunity. So much so, it could provide much-needed relief for nearly 700 million people around the world with mental health issues.
The incredible thing is, it could all start with a small dose of psychedelics, like psilocybin. Not only is the US FDA supportive of research, dozens of medical studies are proving such treatments are impactful, including Johns Hopkins Medicine and New York University.
Even cities and states around the U.S. have begun to decriminalize the use of psilocybin. Better, according to Compass Pathways’ CEO George Goldsmith, “A single experience, a single dose of psilocybin for many people, can create an immediate and sustained benefit for people suffering with depression.”